Visunex Raises $20 Million in Series B Funding for Newborn Imaging Technology

May 12, 2017: By Jon Swedien

Vixunex logoVisunex Medical Systems, a manufacturer of advanced wireless, wide-field imaging systems for newborn infants, raised $20 million in a Series B funding, the Fremont, California, company announced May 5.

The firm introduced in 2016 the first wireless digital imaging platform for imaging the eye of neonatal and full term infants—the PanoCam LT.

“This new round of funding brings the total investment into Visunex Medical to $32 million and will allow the company to expand manufacturing operations to meet the market demand,” said Wei Su, PhD, Visunex’ founder and CEO.

Su said Visunex will also use the money to increase research and development.

Visunex said It will soon be adding a third imaging system to the PanoCam family, which currently consists of the LT and Pro wireless wide-field imaging systems. The new configuration is intended to expand the newborn and infant imaging market, the company said.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

FDA Ophthalmic Devices Panel to hold Meeting Oct. 27

Novartis’ RTH258 Successful in Two Phase III Studies for nAMD

Ocugen Closes $7.5 Million Series B Round

Genentech Uses Vital Art and Science Vision-Testing App in Phase II Study of Sustained Delivery of Lucentis

US Supreme Court Ruling Shortens Time to Market for Biosimilars

Ellex Acquires Royalty Commitment for iTrack Device for $2.15 Million

Johnson & Johnson Vision Names Jonathan Talamo, MD, Chief Medical Officer

Teva Launches Generic Versions of Pataday in US

David Karcher Stepping Down as Executive Director, CEO of ASCRS

EyeGate Raises $10 Million in Public Offering

Aerie Raises $125 Million through Upsized Public Offering, ATM Program

pSivida’s Durasert for Posterior Segment Uveitis Successful in Second Phase III Study

Mynosys Zepto Receives US FDA 510(k) Clearance

Ozurdex, Humira Gain NICE Backing for Non-infectious Posterior Uveitis

Roger Steinert, Pioneer in Ophthalmology, Dies at 66

Carl Zeiss Meditec to Build New Innovation Center in Northern California

Gottlieb Says FDA to Publish List of Drugs Without Generic Competition

REGENXBIO Announces Phase I Clinical Trial for RGX-314 Gene Therapy for Wet AMD

Belkin Laser Closes Nearly $5 Million Financing Round

Valeant in Talks to Sell Surgical Business to Carl Zeiss Meditec

Coming soon

2017 Cataract Surgical Equipment: A Global Market Analysis for 2016 to 2022